Goodman D S
Drugs. 1987;33 Suppl 1:47-55. doi: 10.2165/00003495-198700331-00008.
Derivatives of arachidonic acid may be involved in atherosclerosis and its clinical complications. There is much interest in pharmacologically manipulating the arachidonic acid cascade as a means of preventing cardiovascular disease. The development of atherosclerosis has been intensively studied and the consequences of cardiovascular or cerebrovascular vessel occlusion are too familiar. Many factors are probably involved, but the role of plasma lipoproteins and the interactions between various constituents of blood and blood vessel walls have received particular attention. The risk of cardiovascular disease associated with high plasma concentrations of the low density lipoproteins and the possible protective effects of high density lipoproteins have been well documented. Much is now known about lipoprotein biochemistry, and the importance of controlling the quantity and quality of dietary lipids has been demonstrated in epidemiological studies. In studies of patients with transient ischaemic attacks, aspirin reduced the risk of stroke and death in males, although these benefits were not as convincingly demonstrated in women. The majority of patients were given aspirin 1300 mg daily, but the optimum dosage was not properly evaluated. Administering aspirin in combination with another antiplatelet drug did not appear to offer any therapeutic advantage in these patients. Aspirin showed a positive, but non-significant trend towards reduced numbers of cardiac events, non-fatal infarcts and total mortality in patients who had experienced at least one myocardial infarction. In contrast, statistically significant beneficial effects were recorded when patients with unstable angina were administered aspirin. The risks of myocardial infarction or coronary death were reduced by 51% in 2 large studies.(ABSTRACT TRUNCATED AT 250 WORDS)
花生四烯酸的衍生物可能与动脉粥样硬化及其临床并发症有关。人们对通过药理学手段调控花生四烯酸级联反应以预防心血管疾病很感兴趣。动脉粥样硬化的发展已得到深入研究,心血管或脑血管阻塞的后果也广为人知。可能涉及许多因素,但血浆脂蛋白的作用以及血液与血管壁各种成分之间的相互作用受到了特别关注。血浆中低密度脂蛋白浓度高与心血管疾病风险之间的关系以及高密度脂蛋白可能的保护作用已有充分记录。现在对脂蛋白生物化学了解很多,并且在流行病学研究中已证明控制膳食脂质的数量和质量的重要性。在短暂性脑缺血发作患者的研究中,阿司匹林降低了男性中风和死亡的风险,尽管在女性中这些益处没有那么令人信服地得到证明。大多数患者每天服用阿司匹林1300毫克,但最佳剂量未得到适当评估。在这些患者中,将阿司匹林与另一种抗血小板药物联合使用似乎没有提供任何治疗优势。对于至少经历过一次心肌梗死的患者,阿司匹林在减少心脏事件、非致命性梗死和总死亡率方面显示出积极但不显著的趋势。相比之下,对不稳定型心绞痛患者使用阿司匹林时记录到了具有统计学意义的有益效果。在两项大型研究中,心肌梗死或冠状动脉死亡的风险降低了51%。(摘要截短至250字)